Dt Investment Partners, LLC Abb Vie Inc. Transaction History

Dt Investment Partners, LLC

$988 Million
Q1 2024

A detailed history of Dt Investment Partners, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Dt Investment Partners, LLC holds 28,595 shares of ABBV stock, worth $4.9 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares

28,595

Previous 28,595 -0.0%

Holding current value

$4.9 Million

Previous $4.43 Million 17.51%

% of portfolio

0.53%

Previous 0.49%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $276,620 - $331,740	2,000 Added 7.52%	28,595 $4.62 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $3.57 Million - $4.09 Million	26,595 New	26,595 $3.57 Million
Q1 2022 May 09, 2022	BUY	$131.98 - $163.75 $108,619 - $134,766	823 Added 3.07%	27,593 $4.47 Million
Q4 2021 Feb 07, 2022	SELL	$107.43 - $135.93 $50,814 - $64,294	-473 Reduced 1.74%	26,770 $3.63 Million
Q3 2021 Oct 13, 2021	SELL	$106.4 - $120.78 $107,038 - $121,504	-1,006 Reduced 3.56%	27,243 $2.94 Million

Q1 2021 May 06, 2021	BUY	$102.3 - $112.62 $120,611 - $132,778	1,179 Added 4.36%	28,249 $3.06 Million
Q3 2020 Oct 29, 2020	SELL	$85.91 - $100.83 $49,999 - $58,683	-582 Reduced 2.1%	27,070 $2.37 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $64,242 - $97,398	-996 Reduced 3.48%	27,652 $2.11 Million
Q4 2019 Jan 28, 2020	BUY	$72.13 - $90.25 $2.07 Million - $2.59 Million	28,648 New	28,648 $2.54 Million
Q2 2019 Jul 30, 2019	SELL	$65.7 - $83.98 $3.3 Million - $4.22 Million	-50,197 Closed	0 $0
Q1 2019 Apr 30, 2019	BUY	$77.14 - $90.79 $233,271 - $274,548	3,024 Added 6.41%	50,197 $4.05 Million
Q4 2018 Jan 30, 2019	BUY	$77.85 - $96.01 $34,176 - $42,148	439 Added 0.94%	47,173 $4.35 Million
Q3 2018 Oct 26, 2018	BUY	$88.91 - $98.84 $276,776 - $307,688	3,113 Added 7.14%	46,734 $4.42 Million
Q2 2018 Jul 25, 2018	BUY	$89.78 - $106.23 $66,616 - $78,822	742 Added 1.73%	43,621 $4.04 Million
Q1 2018 May 04, 2018	SELL	$92.01 - $123.21 $11,041 - $14,785	-120 Reduced 0.28%	42,879 $4.06 Million
Q4 2017 Jan 30, 2018	BUY	$89.56 - $98.21 $163,894 - $179,724	1,830 Added 4.45%	42,999 $4.16 Million
Q3 2017 Nov 07, 2017	BUY	$69.85 - $89.22 $2.88 Million - $3.67 Million	41,169	41,169 $3.66 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dt Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dt Investment Partners, LLC with notifications on news.

Account

Dt Investment Partners, LLC Abb Vie Inc. Transaction History